欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3432/001
药品名称Emtricitabine/Tenofovirdisoproxil Teva 200/245 mg, filmomhulde tabletten.
活性成分
    • Emtricitabine 200.0 mg
    • Tenofovir 245.0 mg
剂型Film-coated tablet
上市许可持有人Teva B.V., Swensweg 5, 2031GA Haarlem, Netherlands
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Slovenia (SI)
      Emtricitabin/dizoproksiltenofovirat Teva 200 mg/245 mg filmsko obložene tablete
    • Croatia (HR)
      Emtricitabin/tenofovirdizoproksil Pliva 200 mg/245 mg filmom obložene tablete
    • Germany (DE)
      Emtricitabin/Tenofovirdisoproxil-ratiopharm 200 mg/245 mg Filmtabletten
    • Denmark (DK)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Emtricitabin/Tenofovir disoproxil ratiopharm 200 mg/245 mg Filmtabletten
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Latvia (LV)
      Emtricitabine/Tenofovir disoproxil Teva 200mg/245mg apvalkotās tabletes
    • Estonia (EE)
      EMTRICITABINE/TENOFOVIR DISOPROXIL TEVA
    • Hungary (HU)
      EMTRICITABINE/TENOFOVIR-DISOPROXIL TEVA 200 mg/245 mg filmtabletta
    • Romania (RO)
      Emtricitabină/Tenofovir disoproxil Teva 200 mg/245 mg comprimate filmate
许可日期2016/04/06
最近更新日期2024/11/22
药物ATC编码
    • J05AR03 tenofovir disoproxil and emtricitabine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase